chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was schedule for first dose Moderna vaccine on 5/5.  Once patient received the vaccine she was handed a vaccine record card for her records and scheduled for her 2nd appointment.  At that time she remembered she already had a vaccine record card.  Upon inspection she had received a Moderna fist dose 11 days prior at  Pharmacy.  She stated that she didn't remember getting that vaccine or any information regarding a 2nd dose at that facility.  On her card, the second dose was noted.
Client states about 36 hours after Tdap was given in her right deltoid her right wrist was swollen and bruised. She also states she had trouble moving her right wrist and hand for 3 days. States no problems at the site of injection. States she did not seek medical care.
Not received 3rd dose; Patient received 1st dose on 07-feb-2019 and 2nd dose administrated 14-feb-2019.; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 71-year-old male patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HAB (Twinrix) for prophylaxis and hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included HEPATITIS A VACCINE + HEPATITIS B VACCINE (TWINRIX).   On 14th February 2019, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, the patient received the 3rd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 14th February 2019, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device and not applicable after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too short. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the drug dose administration interval too short and incomplete course of vaccination were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 24th March 2022 Reporter's Comments: The pharmacist reported that a the patient received a second dose of Twinrix  outside recommended schedule. The first dose  was administrated on 7th February 2019 and the second dose administrated on 14th February 2019. No know side effect reported. The vaccine was administrated on another facility. The reporter consented to follow up.  Additional Supportive Information: The patient received 1st and 2nd dose 7 days apart and it should be 1 month, which led to shortening of vaccination schedule. The patient did not received 3rd dose which led to incomplete course of vaccination
Fever appeared 6 days after vaccination, starting with extremely low grade and eventually reaching 101.5 degrees F after two days.  Fever broke after 3 days.  Then rash appeared on torso, followed by rash on limbs and face.  Rash lasted 5 days.  Also diarrhea for 24 hours after the fever broke while rash was inflamed.
administered only the liquid adjuvant; administered only the liquid adjuvant; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number ANXA656A, expiry date 30th August 2023) for prophylaxis.   On 8th April 2022, the patient received the 1st dose of Menveo. On 8th April 2022, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 8-Apr-2022 Reporter's comments: The patient was administered with only the liquid adjuvant of the Menveo vaccine. The consent to follow-up was given. Additional Supportive Information: The patient received only liquid adjuvant of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown
CHILLS, SEVERE HEADACHE, AND TIREDNESS. STARTED THIS MORNING 1/13/21 WHEN I WOKE UP.
Patient presented covered in a rash on body and felt like she was swelling. She noted onset as 30minutes prior around 3pm Sat 08/17. Patient was sent to ER. Upon following up with patient on 08/18 she stated ER physician assess allergic reaction as being brought on by something that she ate. He noted the vaccine had been administered 2 days prior but felt any reaction around injection site was normal. Patient symptoms had resolved as of Sunday 4pm 08/18.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Sep2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 66 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Lymphoma" (unspecified if ongoing), notes: 7 year cancer survivor from Lymphoma. Concomitant medication(s) included: BENZONATATE, start date: 29May2022, stop date: 08Jun2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Indication: Covid-19 treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: After feeling better at the end of my Paxlovid treatment I felt well. Approx a week after I took the Paxlovid my symptoms returned. My symptoms were not as intense as my original symptoms. I had a runny nose and cough for Approx 5 days. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Redness, warmth, edema upper arm below elbow involvement with peri-articular soft tissue swelling (LRG)
Pregnant pt with a due date of 10/26/21, came to clinic for an ob ck, wanting Moderna vaccine, pt will be tuning 18 yrs old in less than 7 days of her visit, Provider aware, vaccine approved to give, pt tolerated vaccine well, no problems with vaccine. Pt has Hx of elevated antibody titers in pregnancy, per PCI no complications from this, is at an increase risk for preeclampsia, pt taking  low dose aspirin per PCI, no other complications or health concerns with pt
Headache, Fever, Diarrhea, NauseaVomiting, site with redness, pain, swelling , itching Narrative:
Patient stated that the arm where the injection was given got the size of a softball, fever in arm for a week, and dehydrated for one day.
THE CLIENT CAME TO THE CLINIC FOR HER 2ND VACCINE.  SHE STATED TO THE GREETER, THE DATA ENTRY ADMIN AND RN VACCINATOR THAT HER FIRST VACCINE WAS PFIZER BRAND AND DID NOT WISH TO RETURN HOME TO RETRIEVE HER FIRST VACCINATION CARD.  SHE GAVE CONSENT TO THE PFIZER VACCINE AND RECEIVED HER NEW VACCINATION CARD.  SHE WAS SEATED IN THE OBSERVATION AREA AND CALLED THE NURSE OVER TO ASK A QUESTION.  SHE POINTED AT THE PFIZER VACCINE ON HER CARD AND STATED THAT HER FIRST VACCINE WAS ACTUALLY MODERNA.  SHE WAS INSTRUCTED TO STAY FOR ONE HALF AND A HALF, GIVEN BOTTLE OF WATER AND PACKAGE OF CRACKERS TO DRINK AND EAT.  AFTER THE TIME WAS OVER, SHE STATED THAT SHE FET WELL WITH NO SIDE EFFECTS AND WAS ALLOWED TO LEAVE FACILITY.
Shingles to left side of face with involvement of left eye with 5th cranial nerve distribution.
My blood pressure is higher than normal and also lower than normal.  Heart palpitation Shortness of breathe  Blur Vision Headache
intermittent heart palpitations; intermittent slight chest pain; both occurred several times over the course of a week
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 09-JAN-2013 the patient was vaccinated with an expired dose of ZOSTAVAX (Lot# reported as 0615AA, expired on 02-JUL-2012, dose and route not reported). No adverse effects were reported. It was not known if the patient sought medical attention. Additional information is not expected.
patient c/o feeling nausea and hot. patient then asked for water. patient then became unresponsive for approximately 30 seconds. seizure like active noted, patient began to have involuntary movement of upper and lower extremities that lasted approximately 10 seconds. Patient accessed for gag reflex and then offered water upon becoming responsive.Patient tolerated water well. Patient offered wet paper towels. Skin noted to be cool and clammy.Vital signs assessed noted to be BP 105/74 and HR 69. Patient alert and oriented x 3,placed in wheelchair for continued observation. Mother stated that syncope activity is normal for patient upon receiving injections or blood draws,seizure like activity is not normal per mother.  Patient taken to observation area by paramedic.
Arm, shoulder and leg pain, no fever within several minutes of vaccination.  Recommended oral hydration and NSAIDs.
Nauseous and threw up 4 days after getting the shot.; I have bad headaches/migraines which I've never had before.; Everytime I go to sleep I have nightmares; I have bad headaches/migraines which I've never had before.; Nauseous and threw up 4 days after getting the shot.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 25Apr2021 15:30 (Batch/Lot number: unknown) at the age of 47 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Vaccine location: Right arm, Lot unknown reason: Unable to locate or read the details, Administration time:03:30 PM, administration date: 04Apr2021, when the patient was 47 years old, for COVID-19 immunization. The following information was reported: MIGRAINE (non-serious), HEADACHE (non-serious) all with onset 29Apr2021 19:00, outcome "not recovered" and all described as "I have bad headaches/migraines which I've never had before."; NIGHTMARE (non-serious) with onset 29Apr2021 19:00, outcome "not recovered", described as "Everytime I go to sleep I have nightmares"; NAUSEA (non-serious) with onset 29Apr2021 19:00, outcome "not recovered", VOMITING (non-serious) with onset May2021, outcome "not recovered" and all described as "Nauseous and threw up 4 days after getting the shot.". Therapeutic measures were not taken as a result of migraine, nightmare, headache, nausea, vomiting.  Additional information: Patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient administered COVID-19 vaccine on other Facility. Patient was not received other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (19Jul2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Per patient, "On June 9, 2015 I went to your clinic for a Tdap vaccine and now I'm having to forgo physical therapy for this arm. I wanted to inform a Manager that this happened. Maybe the shot was given too high in the arm. It felt funny. Not only the normal pain associated with the vaccine but it felt weird. It hurt if I lay on that side, it hurt when driving. The whole left arm and shoulder area, any movement with that arm causes pain."
Felt dizzy and had headache after getting up at 11am on */18/2010.  Tried to work at home but had to lay down because of dizziness.  Left arm was painful since getting the shot, but client noticed redness and swelling and heat at injection site starting Wednesday AM and continuing today.
Severely swollen right submandibular lymph node that   is still swollen today. Ultrasound of thyroid and lymph node Blood work showed increased WBC Sent to Hematologist/ Oncologist- said he didn't know what was the reason for swollen gland, sent to ENT ENT felt that the swelling could he related to submandibular salivary gland Had surgery March 2022, removed an infected right submandibular salivary gland I have had several follow up appointments due to problems with surgical area. The submandibular lymph node is still swollen, the last treatment he gave me was an antibiotic but the node remains swollen. To see hematology May 3rd. Calling ENT for appointment tomorrow.
when he received the vaccine, the liquid in the syringe was light blueish; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT COLOUR ISSUE (when he received the vaccine, the liquid in the syringe was light blueish) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04621A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 16-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced PRODUCT COLOUR ISSUE (when he received the vaccine, the liquid in the syringe was light blueish). On 16-Sep-2021, PRODUCT COLOUR ISSUE (when he received the vaccine, the liquid in the syringe was light blueish) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatement of medication was reported. Concomitant medication included supplements.
c/o dizziness and weakness B/P 150/62, HR 64, O2Sat 98% 10:15am Patient left, stated she is feeling much better.  Recommended to call 911 or contact Primary Care Physician if still has issues.  Understanding verbalized.
Severe bleeding during period.She has been on her period for 14 days; This is a spontaneous report from a contactable consumer or other non hcp. A 26-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: Not reported), via an unspecified route of administration, in right arm (at the age of 26-year-old) on 08Jun2021 at 10:00 as dose number unknown, single for COVID-19 immunization. Medical history included COVID-19 from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of the vaccination. On 09Jun2021, the patient experienced severe bleeding during period. She had been on her period for 14 days straight till the day of reporting (which is abnormally long for her) and the bleeding was abnormally heavy, where no matter how many tampons and pads she wore (sometimes both) it will seep through. This had been consistent for the last 14 days. The patient did not receive treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The outcome of event was not recovered.   Information regarding the Lot/Batch number has been requested.
p/vax local rxn site lt arm pain, swelling, inc warmth, induration or lump w/o abscess;adenopathy local inj site area;pain in joints;neuritis, neuralgia;paresthesias;tingling lt arm;
Beginning early April, I started developing sinus issues that we felt were related to the heavy pollen load. I received the 4th dose of Moderna on 04/28/2022 (lot#: 056A22A). It seemed to settle more so into my chest at the beginning of May and over the course of May it settled into the right side of my chest. At the same time, I would have a wavering temp from 97-99. On 05/31/2022, I had just felt the chest congestion had been getting worse and was concerned due to the 2 possible exposures to COVID (explained below). They did a chest x-ray which was normal. They did a PCR COVID test and it said they didn't detect COVID but told me to be careful since I had been exposed. I now have an appointment with my healthcare provider to follow up (06/16/2022). Around 05/19/2022, I was notified that I had been possible exposed to COVID but we felt it was unlikely because of wearing an K95 mask and only being in the store for a brief time (<10 min). Then around 05/24/2022, a maintenance worker came over and worked at our house and then later that week tested positive for COVID (05/27/2022) but was not showing symptoms at the time he was here.
Significant diarrehri; vomiting; severe dehydration; kidney damage; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm at 14:15 on 27Feb2021 (Batch/Lot number was not reported) at single dose for COVID-19 immunization. Medical history included Crohn's disease. On 28Feb2021, the patient experienced significant diarrehri (diarrhoea) and vomiting resulting in hospitalization for 3 days for severe dehydration and kidney damage. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received over the counter medications within 2 weeks of vaccination. The adverse event resulted Emergency room/department or urgent care and admitted for 3 days. Treatment (IV of fluids and pain medications and anti-nausea) received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19. The outcome of events was recovering.  Information on the lot/batch number has been requested.
24 h after HPV vaccine given - patient had orthostatic syncope - awoke immediately on becoming horizontal.
Woke up with very high blood pressure, racing pulse, a bit of afib, nausea and dizziness; I thought I was having a heart attack, so I went to the emergency
Within 7-10 days of vaccine administration, developed severe urinary irritation, negative to UTI/active infection. Symptoms worsened to the point where patient was unable to walk without pain. Self-treated with OTC Azo (phenazopyridine) until able to make a doctor's appointment.  Possible exacerbation of interstitial cystitis.
Body aches/fatigue after vaccine same day. In addition, gross hematuria x 2 days. 3rd day (today)  has microscopic hematuria in our clinic. No additional urine symptoms. No vaginal bleeding.
localized rash on left shoulder: no fluctuance, induration, tender to touch, measures 6x2.5cm, erythema with central 9 days after vaccination
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown demographics. On an unspecified date since 18-APR-2016, the patient was administered a dose of ZOSTAVAX (lot #L044530; expiry date: 09-FEB-2017) that was improperly stored. No adverse effects were reported. Temperature/Time frame was 46F for 240 hours. There were no previous temperature excursions. This call was not because of a data logger. The outcome was unknown. No product quality complaint was involved. Additional information has been requested.
PNEUMOVAX: Redness in upper left arm quadrant slightly swollen, sore muscle, -> got on BENADRYL QID.
Narrative:  72 yo M with a history of hypertension, hyperlipidemia and CHADS2 paroxysmal atrial fibrillation with a history of med noncompliance. On Friday, 02/12/2021, patient received his 1st Pfizer COVID-19 vaccine.  On Monday, 02/22/2021, patient called the Telephone Care Program (TCP). Per the TCP note, FEB 12- first Pfizer vaccine, no issues except sore arm and then Thursday lost control of the muscles in his face" and "he can not close his left eye and his left side of his face is paralyzed or  drooping as well. He said he did not call the for advise days ago because he read on the internet that it would go away in 5 days. Now he is concerned because it has not gone away." Patient initially reluctant to present to hospital because he thought nothing could be done and wanted to continue on with the second COVID-19 vaccine dose. He received his second COVID-19 vaccine on 03/05/2021. Per 3/8/21 primary care sameday appointment, patient reported that he couldn't open left eye. Diagnosed with Bell's palsy secondary to COVID vaccination. Low suspicion for CVA (No difficulty swallowing but difficulty chewing. No problems with speech,  no headache, no doubled/blurred vision, no tinnitus, difficulty with sound, no numbness or tingling in the upper extremities, loss of smell, no confusion, and no balancing difficulties.) He was recommended to wear an eye patch and use artificial tears. Per 5/3/21 visit with his primary care provider, chiropractic consult, the patient has had some improvement with his Bell's Palsy symptoms.  "...he states he has had improvement: 50% in the forehead, 20% with cheeks and facial, 50% with mouth movements. He denies any changes with closing his left eyelid. He states he has noticed that he is unable to open his right eye while the  left eye is manually shut.; Per the 6/25/21, acupuncture/chiro follow up note, the patient, "presents with 0/10 face pain, he is now able to wink though not yet able to move orbicularis oris." Per 7/23/21 acupuncture/chiro follow up note, "He is able to demonstrate full function of the left eye though still has issue with drinking and droll out of the mouth."
This 59 yo contractor was referred to for HA, dizziness and nausea after her first COVID vaccine.  She received Pfizer COVID vaccine on 12/31/2020. She advised 8 hours later she developed a severe headache. She advised she took 800 mg Ibuprofen and 4 hours later took 1000mg Tylenol and was able to go to sleep. She awoke the next day with her headache persisting and was nauseated. She stated she would alternate Ibuprofen and Tylenol every 4 hours and drink gatorade/water (appetite was low and didn't eat).  She denied any fever, rash, SOB, arthralgia, myalgia or other systemic symptoms.  Day 4 post vaccination (1/4/2021) she cut med use down to every 8 hours. She stated use of Ibuprofen/Tylenol did resolve
Systemic: Dizziness / Lightheadness-Mild, Additional Details: patietn said dizziness occurred  within the 15 minutes while she was waiting post vaccine
My yearly physical was at 8:00 a.m. Dr completed my exam and then suggested that I receive a Pneumovax injection.  I reminded him that I had previously received a pneumonia shot as well as Prevnar 13.  He mentioned that those injections had been administered prior to my 65th birthday.  He wanted me to have this additional vaccine.  He was to retire in October and I did not want to end a good relationship on a negative note. I received the injection.  I walked out of his office at 9:00 a.m.  By noon on that same day I was in bed.  I had fever, chills, body aches and a very painful arm.  I was in bed for three days.  I had a bag of fluid that began at the injection site and eventually moved below my right elbow.  As I have aged, any and all vaccinations have caused me to feel ill.  Therefore, I stopped receiving flu vaccines.
5-1 minutes after 1st injection patient became very nauseous and had near syncopal episode. She as diaphoretic and complained of feeling very weak and lightheaded. She almost collapsed to the ground. She was severely hypertensive. EMS was called and patient transported to nearest ER. Denied any diffciulty in breathing, chest pain, or any other signs of allergic reaction.
Right deltoid area with large area of redness and mild tenderness- (within 24 hours of receiving DaPT and IPV)